Condensed Statements of Income (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Product sales	$ 2,506,932	$ 2,278,235	$ 5,127,766	$ 4,767,778
Cost of products sold	912,406	744,108	1,795,403	1,556,152
Gross profit	1,594,526	1,534,127	3,332,363	3,211,626
Selling, general and administrative expenses	1,517,854	1,340,129	2,910,724	2,728,031
Research and development expenses	29,165	42,885	44,885	164,722
Total operating expenses	1,547,019	1,383,014	2,955,609	2,892,752
Income from operations	47,507	151,113	376,754	318,874
Other income (expenses)
Other income				17,543
Interest income (expense)	635	(30,011)	161	(64,569)
Loss on Earnings from Medical Joint Venture	(213,193)	(47,093)	(343,716)	(47,093)
Loss on Earnings from Education Joint Venture	(4,406)		(7,822)
Total other expenses, net	(216,964)	(77,104)	(351,377)	(94,119)
Net (loss) income applicable to common stockholders	$ (169,457)	$ 74,009	$ 25,377	$ 224,754
Net (loss) income per share applicable to common stockholders -
Basic	$ (0.01)	$ 0.00	$ 0.00	$ 0.01
Diluted	$ (0.01)	$ 0.00	$ 0.00	$ 0.01
Weighted average shares outstanding and to be issued -
Basic	20,246,281	16,744,951	19,196,919	16,765,602
Diluted	20,248,281	17,056,219	22,206,942	17,124,936